|
Post by lakers on Feb 27, 2016 17:26:50 GMT -5
Google Life Sciences (Verily) earlier this week announced a partnership with Sanofi, maker of an insulin inhaler and a slew of other products for people with diabetes. Google is also working with Johnson & Johnson on surgical robots, Biogen on potential treatments for multiple sclerosis and Novartis and Dexcom on diabetes-related projects. www.npr.org/sections/health-shots/2015/09/06/437570402/why-google-is-going-all-in-on-diabetesCheck out the VDEX Symbol with Black V in circle (contact lense) and DEX in Blue - 2 different designs. Verily symbol is a single underlined "V". DEXcom symbol is "DEXCOM". www.vdexdiabetes.comAlfred E. Mann, 1925 - 2016 Vdex Diabetes [Real Time Diabetes Control] is dedicated to the memory of Alfred Mann who was responsible for the betterment of so many lives both diabetic and otherwise. Al lived his life in a manner that serves as a model to us all. His focus, both personally and professionally, was on solving problems for others. We at Vdex strive humbly to carry on his legacy in the field of diabetes. Whatever success we enjoy will forever rest upon the foundation created by Al Mann. Beginning with a single office in New Jersey and two more to follow closely behind, we have ambitions to introduce our model of diabetes care throughout the United States. Please check back to see new locations as they are added across the country. Selecting a pin below will enable you to see website and direction information for each VDex location.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 27, 2016 17:29:53 GMT -5
No .. its not something google would get into..treatment centers?
|
|
|
Post by lakers on Feb 27, 2016 17:32:47 GMT -5
No .. its not something google would get into..treatment centers? Could it be a JV startup funded by Verily and DEXcom? It fits their treatment vision. The VDEX doesn't sound like a single meaningful word. It seems a joint entity?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 27, 2016 17:34:43 GMT -5
No .. its not something google would get into..treatment centers? Could it be a JV startup funded by Verily and DEXcom? It fits their treatment vision. No.. its made clear in one of the threads that this idea came in from Mannkind investors...No big player involvement
|
|
|
Post by stevil on Feb 27, 2016 17:35:35 GMT -5
I know someone that works at Lilly in the marketing/research department. I was told that they were very excited about a pump in the near future that will read blood sugar in real time and release either insulin or glucagon to keep the blood within physiological limits. It's effectively an artificial pancreas.
I'm not sure if this is similar to that or not, but thought I'd share what I'd heard. They weren't allowed to divulge too many details. That's about all that I know about it.
|
|
|
Post by lakers on Feb 27, 2016 17:39:02 GMT -5
Could it be a JV startup funded by Verily and DEXcom? It fits their treatment vision. No.. its made clear in one of the threads that this idea came in from Mannkind investors...No big player involvement VDEX must be very deep pocketed. It must be funded by big players. "Beginning with a single office in New Jersey and two more to follow closely behind, we have ambitions to introduce our model of diabetes care throughout the United States. Please check back to see new locations as they are added across the country."
|
|
|
Post by LosingMyBullishness on Feb 27, 2016 17:47:26 GMT -5
No.. its made clear in one of the threads that this idea came in from Mannkind investors...No big player involvement VDEX must be very deep pocketed. It must be funded by big players. "Beginning with a single office in New Jersey and two more to follow closely behind, we have ambitions to introduce our model of diabetes care throughout the United States. Please check back to see new locations as they are added across the country." Lakers, What makes you believe that they need to have deep pockets, well beyond the capacity of some MNKD investors. They utilize the infrastructure of existing, smaller care centre companies, have some few equipment and an endo on telephone standby. Does not sound expensive to me. Adding centers means to do more contracts.
|
|
|
Post by lakers on Feb 27, 2016 17:53:55 GMT -5
VDEX must be very deep pocketed. It must be funded by big players. "Beginning with a single office in New Jersey and two more to follow closely behind, we have ambitions to introduce our model of diabetes care throughout the United States. Please check back to see new locations as they are added across the country." Lakers, What makes you believe that they need to have deep pockets, well beyond the capacity of some MNKD investors. They utilize the infrastructure of existing, smaller care centre companies, have some few equipment and an endo on telephone standby. Does not sound expensive to me. Adding centers means to do more contracts. This is the same concept as store within store, Apple, Samsung stores within Thousands of Best Buy stores nationwide. Apple, Samsung paid a lot to do just that. Small player can't afford that. Matt's slide mentioned large scale deployment.
|
|
|
Post by LosingMyBullishness on Feb 27, 2016 18:02:29 GMT -5
Lakers, What makes you believe that they need to have deep pockets, well beyond the capacity of some MNKD investors. They utilize the infrastructure of existing, smaller care centre companies, have some few equipment and an endo on telephone standby. Does not sound expensive to me. Adding centers means to do more contracts. This is the same concept as store within store, Apple, Samsung stores within Thousands of Best Buy stores nationwide. Apple, Samsung paid a lot to do just that. Small player can't afford that. Matt's slide mentioned large scale deployment. Good point. Why haven't they put up a disclaimer if they are an established company? Even if Dexcom is involved in it, why don't they disclose this? No need to hide.
|
|
|
Post by victoria on Feb 27, 2016 18:11:25 GMT -5
|
|
|
Post by mindovermatter on Feb 27, 2016 18:11:33 GMT -5
I know someone that works at Lilly in the marketing/research department. I was told that they were very excited about a pump in the near future that will read blood sugar in real time and release either insulin or glucagon to keep the blood within physiological limits. It's effectively an artificial pancreas. I'm not sure if this is similar to that or not, but thought I'd share what I'd heard. They weren't allowed to divulge too many details. That's about all that I know about it. One thing that artificial pumps can't handle is glucose spikes during eating, or that is what I have read from those who follow AP closely. We do know that Sansum has done AP testing and used Afrezza as the meal time insulin. Here's the video. www.youtube.com/watch?v=GGgGjtM5ipg
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 27, 2016 18:13:45 GMT -5
I know someone that works at Lilly in the marketing/research department. I was told that they were very excited about a pump in the near future that will read blood sugar in real time and release either insulin or glucagon to keep the blood within physiological limits. It's effectively an artificial pancreas. I'm not sure if this is similar to that or not, but thought I'd share what I'd heard. They weren't allowed to divulge too many details. That's about all that I know about it. One thing that artificial pumps can't handle is glucose spikes during eating, or that is what I have read from those who follow AP closely. We do know that Sansum has done AP testing and used Afrezza as the meal time insulin. Here's the video. www.youtube.com/watch?v=GGgGjtM5ipgand the costs of pump.. by then afrezza would have proved first phase insulin , no pre dawn effect?
|
|
|
Post by mindovermatter on Feb 27, 2016 18:16:02 GMT -5
Thanks for shining some sunshine of truth on this ridiculous thread! You'd think some on here who pride themselves on their investigative googling would have quickly figured this out and stopped themselves from posting this ridiculous theory that you just debunked with rapid speed.
|
|
|
Post by agedhippie on Feb 27, 2016 18:25:05 GMT -5
The point with the artificial pancreas is that you go not need to do anything other than periodically top up a pump and change a site or sensor. You can eat when and what you want without any manual dosing, you can exercise, you can live a normal life without worrying whether you are high or low.
It will be expensive though and beyond most Type 1 and a few Type 2 diabetics nobody else will get it in the US.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 27, 2016 18:31:03 GMT -5
The point with the artificial pancreas is that you go not need to do anything other than periodically top up a pump and change a site or sensor. You can eat when and what you want without any manual dosing, you can exercise, you can live a normal life without worrying whether you are high or low. It will be expensive though and beyond most Type 1 and a few Type 2 diabetics nobody else will get it in the US. pump and a normal life? there's nothing normal with a pump..
|
|